How IIT Bombay’s New Placenta-on-Chip Mimics Pregnancy

Indian researchers have achieved a major breakthrough in maternal-fetal health research. Specifically, scientists from IIT Bombay and ICMR-NIRWoH developed an indigenous placenta-on-chip platform to mimic the human placenta. This novel device closely replicates the interface between mother and fetus in a controlled laboratory setting. Consequently, it offers a safer and more ethical alternative to traditional preclinical testing methods, which is a significant advancement for professionals focused on obstetrics and gynaecology research.

Understanding the Placenta-on-Chip Platform

The placenta is a vital but highly complex temporary organ. Crucially, it regulates the transfer of nutrients, oxygen, and waste between mother and fetus. However, studying these functions directly during pregnancy is ethically challenging. To solve this, researchers engineered a compact, two-chamber microfluidic device. This platform grows human placental and blood vessel cells on opposite sides of a porous membrane. Furthermore, the model successfully reproduces key physiological actions, including hormone secretion and barrier functions.

Advantages Over Traditional Research Models

Why is this model a game-changer? Currently, scientists rely heavily on animal models to test drug safety. However, animal placentas differ significantly from human ones. Therefore, preclinical trials often yield inaccurate results. This new Indian platform offers a human-relevant model that increases predictive accuracy. Additionally, it features a simpler design compared to complex Western organ-on-chip systems. As a result, standard laboratories can easily manufacture and operate it without highly specialized infrastructure.

Clinical and Regulatory Implications in India

This innovation could significantly accelerate safe drug discovery for pregnant women. Currently, clinicians struggle because very few medicines are approved as “pregnancy-safe.” With this platform, pharmaceutical companies can rigorously evaluate drug transfer. Moreover, researchers can study complex pregnancy disorders like preeclampsia and gestational diabetes. Ultimately, this local technology will strengthen India’s biomedical research capacity and support maternal health, reinforcing the importance of electronic fetal monitoring and advanced diagnostics in modern clinical practice.

Frequently Asked Questions

Q1: What is a placenta-on-chip platform?

It is a microfluidic device that mimics the structure and transport functions of the human placenta using real human cells.

Q2: How does this device help pregnant women?

It allows scientists to safely test how medicines and nutrients cross the maternal-fetal barrier, ensuring drug safety during pregnancy.

Q3: Why is this platform better than existing models?

Unlike complex systems, this indigenous platform is simpler to manufacture, cheaper to operate, and reduces reliance on animal testing, which is a priority for those training in obstetrics, gynecology, and women’s health.

References

1. IIT Bombay scientists develop placenta-on-chip to aid foetal research – ETHealthworld
2. Indian scientists recreate key functions of human Placenta on chip – The Hindu
3. A Functional Placenta-On-Chip Model For Maternal–Fetal Transport – Biofabrication

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.